StockData
Tevogen Inc. logo

Tevogen Inc. (TVGN) stock

TVGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGNW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$5.69−0.53 (-8.52%)

Close on Nov 17, 2026Market cap $37.05MP/E –Yield –

Tevogen enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Tevogen's enterprise value was $24.45M on Nov 11, 2026, against $86.05M a year earlier. Over the last 3 years it ranged from $17.62M to $931.35M, with a median of $104.04M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$24.45M-62.0%
2025Dec 31, 2025$64.32M-62.9%
2024Dec 31, 2024$173.57M+737.3%
2023Apr 28, 2023$20.73M–

More Tevogen figures

See a number that looks wrong?